Abstract
The subject of this paper is the problematisation of depression in today’s mental health care. It is based on a study of the professional discussion on depression in Finland from the mid-1980s to the 1990s. The ways in which Finnish mental health experts define the object of depression treatment bring out an ambivalence that stems from the discrepancy between two parallel but incongruent notions of what depression is: the psychopharmacological and the psychotherapeutic. The analysis of the discussion demonstrates how clinical and practical rationales of today’s mental health care are formed in the space between the two poles. Two tendencies of these rationales are also pointed out: first, the DSM paradigm of depressive illness inclines to become problematic and to dissolve in the actual practices. Second, they insinuate emphasis on antidepressant medication and overall neuropsychiatric approach in the treatment of depressive disorders, although in an ambivalent way.
Similar content being viewed by others
Notes
See Klerman, “The nature of depression: mood, symptom, disorder”.
Henriksson, Isometsä, Huttunen and Lönnqvist, “Masennustilojen diagnostiikan keskeisiä käsitteitä ja ongelmia,” 227.
See Jackson, Melancholia and Depression; Rousseau, “Depression’s forgotten genealogy”; Radden, “Introduction: From melancholic states to clinical depression”; Radden, “Is this dame melancholy?”
See Martin, “Illness, insight, and identity”; Ghaemi, “Depression: illness, insight, and psychopharmacological Calvinism”; Ehrenberg, La fatigue d’être soi; Kramer, “The valorization of sadness”; Elliott: “Pursued by happiness and beaten senseless”.
See. Wilson, “Melancholic biology”.
See. Martin; Wilson; Ehrenberg.
My study is based on analyses of articles and research reports on clinical aspects, epidemiology, and treatment of depressive illness in Finnish medical and psychiatric journals (Psychiatria Fennica, Duodecim, and Suomen lääkärilehti), textbooks, special issues of journals, and guidelines and instructions for diagnosis and treatment of depression and for the use of antidepressants. Articles published in international psychiatric or medical journals by Finnish doctors are also included in the data.
See Hale, The Rise and Fall in Psychoanalysis in the United States, 276–299; Metzl, Prozac on the Couch, 71–98.
See Hale, 185–379; Luhrman, Of Two Minds, 158–265.
Depressio—tunnistaminen ja hoito, 4.
Tamminen, Mielet maasta, 52.
For a review, see Regier, Goldberg and Taube, “The de facto US mental health services system: a public health perspective”; Blacker and Clare, “Depressive disorder in primary care”; Katon, “The epidemiology of depression in primary care”; Katon and Schulberg, “Epidemiology of depression in primary care”.
Castel, Castel and Lovell, The Psychiatric Society, 60–213; Grob, From Asylum to Community, 209–301; Shorter, A History of Psychiatry, 229–238, 227–280.
Salo, Sietämisestä solidaarisuuteen, 195–268; Taipale, “Hallitusta muutoksesta hallitsemattomaan alasajoon?”
Lönnqvist, “National suicide prevention project in Finland: a research phase of the project”; Isometsä, Henriksson, Aro, Heikkinen, Kuoppasalmi and Lönnqvist, “Suicide in major depression”.
Finnish Statistics on Medicines 1988–2004. The new type of antidepressants were approved in Finland almost immediately after fluoxetine (Prozac) was launched to the main U.S. market in 1988; see Healy, Let Them Eat Prozac, 37–39.
Cf., Glenmullen, Prozac Backlash; Healy, Let Them Eat Prozac
Poutanen, “Depression in the primary health care patient”, 125.
Achté and Tamminen, Depressio ja sen hoito, 11; Tamminen, Depression tunnistaminen, 3.
Shorter, passim.
Hale, 300–321; Shorter, 26, 238, 305–313; Luhrmann, 203–238; Healy, The Antidepressant Era, 103, 157, 163.
Berrios, The History of Mental Symptoms, 15–22; Castel, The Regulation of Madness, 85–97; Shorter, 17–29, 69–77.
On the latter, see Danziger, Naming the Mind, 124–131.
On this concept, see Hacking, Historical Ontology, 173–175, 190–192.
Salokangas, Kliininen depressio, 107.
Ibid., 6.
Ibid., 26.
Ibid., 25–26.
Ibid., 91.
Ibid., 162.
On the design and results of TADEP, see Salokangas, Poutanen and Stengård, “Screening for depression in primary care”; Salokangas et al., “Prevalence of depression among patients seen in community health centres and community mental health centres”: Poutanen, “Depression in the primary health care patient”; Poutanen, Depressio terveyskeskuspotilailla.
Radden, “Introduction: from melancholic states to clinical depression,” 49–51.
Paykel and Priest, “Recognition and management of depression in general practice: consensus statement”, 1198.
See Poutanen, Depressio terveyskeskuspotilailla, 45–47.
For a review, see Blacker and Clare.
Regier et al., “The NIMH Depression Awareness, Recognition, and Treatment Program: Structure, aims, and scientific basis”; Rutz et al. “An educational programme on depressive disorder for general practitioners on Gotland: background and evaluation”; Priest, “Improving the management and knowledge in general practice in the UK Educational Programme”; Katon et al., “Collaborative management to achieve treatment guidelines”; see also Healy, Let Them Eat Prozac, 8–11.
“Mood disorders: pharmacological prevention of recurrences”; “Pharmacotherapy of depressive disorders”; “Practice guideline for major depressive disorders in adults”; Depression in primary care, vols 1 and 2; Paykel and Priest; see also Spigset and Mårtensson, “Drug treatment of depression”.
Wilson, “DSM-III and the transformation of American psychiatry”. For a detaild analysis, see Kirk and Kutchins, The Selling of DSM.
Ian Hacking developed this concept by further elaborating A. C. Crombie’s (Styles of Scientific Thinking in the European Tradition) analysis of six styles of thinking in the history of Western science. Hacking, Historical Ontology, 159–199.
Forrester, “If p, then what? Thinking in cases”.
See Cooper, “What is wrong with the DSM?”
See Henriksson, Isometsä, Huttunen and Lönnqvist; Riikonen and Mattila, “Ovatko psykiatriset ongelmakäsitykset ja—luokitukset masentavia?”
For an overview, see Kutchins and Kirk, Making Us Crazy.
Healy, The Antidepressant Era, 48–56, 76–77.
Ibid., 98–99.
DSM-IV-TR, xxxi.
This concept is Annemarie Mol’s, in her book The Body Multiple.
See Paykel and Priest; Widmer and Cadoret, “Depression in primary care”; Goldberg, “Detection and assessment of emotional disorders in a primary care setting”; Freeling et al., “Unrecognised depression in general practice”; Freeling, “Diagnosis and treatment of depression in general practice”.
Paykel and Priest, 1198.
See DSM-IV-TR, 679–683.
Poutanen, Depressio terveyskeskuspotilailla, 45.
Spigset and Mårtensson, 1188.
For the similar emphasis in the U.S., see Tasman, Riba and Silk, The Doctor-patient Relationship in Pharmacotherapy.
Healy, Let Them Eat Prozac, 2, 7–11; Rose, “Becoming of neurochemical selves”.
Depression in primary care, vol 1 and 2.
Ian Hacking and Allan Young present fine illustrations of how psychic phenomena are transformed into facts of empirical sciences by triangulating. See Hacking, “Memory sciences, memory politics,” 70–76 and Young, The Harmony of Illusions, 134–135.
Depression in primary care, vol. 2, 23, 35.
Rimón and Rimón, “Depression hoito terveyskeskuksessa”; Achté, “Psykofarmakologian vuosikymmenet”.
On professional, public and judical controversies over the SSRIs since the late 1980s, see Glenmullen; Healy, Let Them Eat Prozac.
Huttunen, “Masennuslääkkeiden laajenevat käyttöaiheet”; Tamminen, Mielet maasta, 150; see also Rose.
Healy, The Anti-depressant Era, 102–103; Healy, Let Them Eat Prozac.
Spigset and Mårtensson, 118; see also Depression in primary care, vol 2, 36.
Poutanen, Depressio terveyskeskuspotilailla, 45.
Tamminen 19.
Lehtinen, Depression hoito terveyskeskuksessa.
Spoov and Syvälahti, Depressiolääkkeet, 57.
Salokangas, 113, 162–163.
References
Achté K. “Psykofarmakologian vuosikymmenet.” In Mielen lääkkeet—lääkkeen mieli: Psykofarmakologian historia Suomessa, eds. S. Kähkönen and T. Partonen (Helsinki: Duodecim, 1999).
Achté, K. and T. Tamminen, eds. Depressio ja sen hoito (Klaukkala: Recallmed, 1993).
Berrios, G. The History of Mental Symptoms: Descriptive Psychopathology since the Nineteenth Century (Cambridge: Cambridge University Press, 1996).
Blacker, CVR. and AW. Clare, “Depressive Disorder in Primary Care.” British Journal of Psychiatry, 150 (1987): 737–751.
Castel, R. The Regulation of Madness: The Origins of Incarceration in France (Cambridge: Polity, 1988).
Castel, R., F. Castel, and A. Lovell, The Psychiatric Society (New York: Columbia University Press, 1982).
Cooper, R. “What Is Wrong with the DSM?” History of Psychiatry, 15 (2004): 5–25.
Crombie, A.C. Styles of Scientific Thinking in the European Tradition, 3 vols. (London: Duckworth, 1994).
Danziger, K. Naming the Mind: How Psychology Found Its Concepts. (London: Sage, 1997).
Depressio—tunnistaminen ja hoito. Konsensuskokous 28.–30.11.1994 (Helsinki: Suomen Akatemia ja Suomalainen Lääkäriseura Duodecim, 1995).
Depression in Primary Care. vol. 1: Detection and Diagnosis. Clinical Practice Guideline Nr 5 (U.S. Department of Health and Human Services, 1993).
Depression in Primary Care. vol. 2: Treatment of Major Depression. Clinical Practice Guideline Nr 5 (U.S. Department of Health and Human Services, 1993).
Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (Washington, DC: American Psychiatric Association, 2000).
Ehrenberg, A. Das ershöpfte Selbst (Frankfurt am Main: Campus, 2004).
Elliott, C. “Pursued by Happiness and Beaten Senseless: Prozac and the American Dream.” In Prozac as a Way of Life, eds. C. Elliott and T. Chambers (Chapel Hill & London: University of North Carolina Press, 2004).
Finnish Statistics on Medicines 1988–2004 (Helsinki: National Health Agency for Medicines & Social Insurance Institution).
Forrester, J. “If p, Then What? Thinking in Cases.” History of the Human Sciences, 9:3 (1996): 1–26.
Freeling, P. “Diagnosis and Treatment of Depression in General Practice.” British Journal of Psychiatry, 163, Supplement 20 (1993): 14–19.
Freeling, P., BM. Rao, ES. Paykel, LI. Sireling, et al. “Unrecognised Depression in General Practice.” British Medical Journal, 290 (1985): 1880–1883.
Ghaemi, SH. “Depression: Insight, Illusion and Psychopharmacological Calvinism.” Philosophy, Psychiatry & Psychology, 6 (1999):287–294.
Glenmullen, J. Prozac Backlash (New York: Touchstone, 2001).
Goldberg, D. “Detection and Assessment of Emotional Disorders in a Primary Care Setting.” International Journal of Mental Health, 8 (1979): 30–48.
Grob, G. From Asylum to Community. Mental Health in Modern America. (Princeton, NJ: Princeton University Press, 1991).
Hacking, I. “Memory Sciences, Memory Politics.” In Tense Past: Cultural Essays in Trauma and Memory, eds. P. Antze and M. Lambek (New York and London: Routledge, 1996).
Hacking, I. Historical Ontology (Cambridge, MA. and London: Harvard University Press, 2002).
Hale, N. The Rise and Fall of Psychoanalysis in the United States. Freud and the Americans, 1917–1985 (New York and Oxford: Oxford University Press, 1995).
Healy, D. The Antidepressant Era. (Cambridge: Harvard University Press, 1997).
Healy, D. Let Them Eat Prozac (New York: New York University Press, 2005).
Henriksson, M., E. Isometsä, MO. Huttunen, and J. Lönnqvist, “Masennustilojen diagnostiikan keskeisiä käsitteitä ja ongelmia.” Duodecim, 110 (1994): 227–237.
Huttunen, MO. “Masennuslääkkeiden laajenevat käyttöaiheet.” Duodecim, 112 (1996):1879–1888.
Isometsä, E., M. Henriksson, H. Aro, M. Heikkinen, K. Kuoppasalmi, et al.. “Suicide in Major Depression.” American Journal of Psychiatry, 151 (1994): 530–536.
Jackson, S. Melancholia and Depression (New Haven: Yale University Press, 1986).
Katon, W. “The Epidemiology of Depression in Primary Care.” International Journal of Psychiatry and Medicine, 17 (1987): 93–111.
Katon, W. and H. Schulberg. “Epidemiology of Depression in Primary Care.” General Hospital Psychiatry, 14 (1992): 237–247.
Katon, W., M. von Korff, E. Lin, E. Walker, GE. Simon, et al. “Collaborative Management to Achieve Treatment Guidelines: Impact on Depression in Primary Care.” Journal of American Medical Association, 273 (1995): 1026–1031.
Kirk, S. and H. Kutchins. The Selling of DSM: The Rhetoric of Science in Psychiatry (New York: de Gruyter, 1992).
Klerman, G. “The Nature of Depression: Mood, Symptom, Disorder.” In The measurement of depression, eds. AJ. Marsella, RM. Hirschfeld and MM. Katz (New York: Wiley, 1987).
Kutchins, H. and S. Kirk. Making Us Crazy: DSM—the Psychiatric Bible and the Creation of Mental Disorders (New York: Free Press, 1997).
Lehtinen, V., ed. Depression hoito terveyskeskuksessa. Tunnistamis—ja hoitomalli (Helsinki: Stakes, 1994).
Luhrmann, TM. Of Two Minds. The Growing Disorder in American Psychiatry (New York: Knopf, 2001).
Lönnqvist, J. “National Suicide Prevention Project in Finland: A Research Phase of the Project.” Psychiatria Fennica, 19 (1988): 125–132.
Martin, MW. “Illness, Insight and Identity.” Philosophy, Psychiatry & Psychology, 6 (1999): 271–286.
Metzl, J. Prozac on the Couch (Durham: Duke University Press, 2003).
Mol, A. The Body Multiple. Ontology in Medical Practice (Durham: Duke University Press, 2002).
“Mood Disorders: Pharmacological Prevention of Recurrences”. NIMH/HIH consensus development conference statement. American Journal of Psychiatry, 142 (1985): 469–476.
Paykel, ES. and RG. Priest. “Recognition and Management of Depression in General Practice: Consensus Statement.” British Medical Journal, 305 (1992): 1198–1202.
Pharmacotherapy of Depressive Disorders: A Consensus Statement” Journal of Affective Disorders, 17 (1989): 197–198.
Poutanen, O. Depressio terveyskeskuspotilailla (Tampere: Tampereen yliopisto, 1996).
Poutanen, O. “Depression in the Primary Health Care Patient: Prevalence, Recognition, Definition and the Consulting Situation.” Psychiatria Fennica, 27 (1996): 115–126.
“Practice Guideline for Major Depressive Disorders in Adults” American Journal of Psychiatry, 150:4, Supplement (1993).
Priest, RG. “Improving the Management and Knowledge in General Practice in the UK Educational Programme.” British Journal of Psychiatry, 164 (1994): 285–287.
Radden, J. “Introduction: From Melancholic States to Clinical Depression.” In The Nature of Melancholy from Aristotle to Kristeva, ed. J. Radden (Oxford: Oxford University Press, 2000).
Radden, J. “Is This Dame Melancholy? Equating Today’s Depression and Past Melancholia.” Philosophy, Psychiatry & Psychology, 10 (2003): 37–52
Regier, DA., ID. Goldberg, and CA. Taube. “The de facto US Mental Health Services System: A Public Health Perspective.” Archives of General Psychiatry, 35 (1978): 685–693.
Regier, DA., R. Hirschfeld, F. Goodwin, J. Burke, et al. “The NIMH Depression Awareness, Recognition, and Treatment Program: Structure, Aims, and Scientific Basis.” American Journal of Psychiatry, 145 (1988): 1351–1357.
Riikonen, E. and A. Mattila. “Ovatko psykiatriset ongelmakäsitykset ja—luokitukset masentavia?” Duodecim, 110 (1994): 347–359.
Rimón, M. and R. Rimón. “Depression hoito terveyskeskuksessa”. Suomen Lääkärilehti, 47 (1992): 2381–2385.
Rose, N. “Becoming of Neurochemical Selves”. In Biotechnology: Between Commerce and Civil Society, ed. N. Stehr (New Brunswick: Transaction, 2004.)
Rousseau, G. “Depression’s Forgotten Genealogy: Notes towards a History of Depression.” History of Psychiatry, 11 (2000): 71–106.
Rutz, W., J. Wålinder, G. Eberhard, G. Holmberg, A-L. von Knorring. “An Educational Programme on Depressive Disorder for General Practitioners on Gotland: Background and Evaluation.” Acta Psychiatrica Scandinavica, 79 (1989): 19–26.
Salo, M. Sietämisestä solidaarisuuteen: Mielisairaalareformit Italiassa ja Suomessa (Tampere: Vastapaino, 1996).
Salokangas, R. Kliininen depressio: Mitä se on ja miten sitä hoidetaan? (Porvoo: WSOY, 1997).
Salokangas, R., O. Poutanen, and E. Stengård. “Screening for Depression in Primary Care: Development and Validation of the Depression Scale (DEPS), a Screening Instrument for Depression.” Acta Psychiatrica Scandinavica, 92 (1995): 9210–9216.
Salokangas, R., O. Poutanen, E. Stengård, R. Jähi, and T. Palo-oja. “Prevalence of Depression among Patients Seen in Community Health Centres and Community Mental Health Centres.” Acta Psychiatrica Scandinavica, 93 (1996): 427–433.
Shorter, E. A History of Psychiatry. From the Era of the Asylum to the Age of Prozac (New York: Wiley, 1997).
Spigset, O. and B. Mårtensson. “Drug Treatment of Depression.” British Medical Journal, 318 (1999): 1188–1191.
Spoov, J. and E. Syvälahti. Depressiolääkkeet: Käyttöaiheet ja hoidon periaatteet. (Helsinki: Lääkelaitos & KELA, 1996).
Taipale, V. “Hallitusta muutoksesta hallitsemattomaan alasajoon?” In Sosiaali—ja terveydenhuollon palvelukatsaus 1997, eds. H. Uusitalo and M. Staff (Helsinki: Stakes, 1997).
Tamminen, T. Depression tunnistaminen: Kliininen diagnostiikka ja hoidon arviointia (Espoo: Novo Nordisk, 1995).
Tamminen, T. Mielet maasta (Klaukkala: Recallmed, 2001).
Tasman, A., MB. Riba, and KR. Silk. The Doctor–Patient Relationship in Pharmacotherapy: Improving Treatment Effectiveness (New York: Guildford, 2000).
Widmer, RB. and RJ. Cadoret. “Depression in Primary Care: Changes in Pattern of Patient Visits and Complaints during a Development of Depression.” Journal of Family Practice 7 (1978): 293–302.
Wilson, E. “Melancholic Biology: Prozac, Freud and Neurological Determination.” Configurations, 7 (1999): 403–419.
Wilson, M. “DSM-III and the Transformation of American Psychiatry: A History.” American Journal of Psychiatry, 150 (1993): 399–410.
Young, A. The Harmony of Illusions. Inventing Post-traumatic Stress Disorder (Princeton, NJ: Princeton University Press, 1995).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Helén, I. Multiple Depression. J Med Humanit 28, 149–172 (2007). https://doi.org/10.1007/s10912-007-9036-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10912-007-9036-y